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Introduction
•

•

•

Aortic stenosis (AS) is a condition
where the opening of the aortic
valve becomes narrower. The
narrowing causes a resistance in
blood flow from the left ventricle
(LV) to the aorta, which results in a
reduction of flow and higher
pressures within the left ventricle
(McCance & Huether, 2014).

•

AS affects about 2% of adults over
the age of 65 (McCance & Huether,
2014).
The most common heart valve
disorder in Europe and North
America is AS due to calcification
(Wald, Williams, Bangash, &
Bestwick, 2018).

Importance
•

AS is increasing in prevalence due to
aging of the population and
increased life expectancy (Kanwar,
Thaden & Nkomo, 2018).

•

Cardiac surgical intensive care unit
(CVICU) nurses and certified
registered nurse anesthetists
(CRNA’s) provide care to many
patients with AS.

•

Pathophysiology
•

Proper education of the underlying
pathology and its significance,
symptoms, and appropriate
diagnosis and treatment is essential
to provide high level nursing care.

•

•

•

Narrowing of the aortic valve is
generally due to three main causes:
1) Age associated calcification, 2)
congenital bicuspid aortic valve and
3) Inflammation associated with
rheumatic heart disease (McCance &
Huether, 2014).
Age associated AS is the end result of
an inflammatory process caused by
endothelial damage due to
mechanical stress, lipid penetration
leading to fibrosis, leaflet thickening,
and finally calcification (Joseph,
Naqvi, Giri, & Goldberg, 2017).
In AS from all causes, the opening of
the aortic valve narrows, causing
diminished blood flow from the LV to
the aorta (McCance & Huether,
2014).
Pressure in the LV rises to overcome
the outflow obstruction caused by
the narrow valve, in an attempt to
preserve stroke volume and cardiac
output. LV hypertrophy develops
due to an increased workload to get
blood across the valve (Yurek, Jakub
& Menacho, 2015).
Increased jet velocity and mean
pressure gradient develop across the
valve, with decreasing valve area
throughout progression of the
disease. AS is generally graded as
mild, moderate, or severe; and the
grading determines the frequency of
echocardiogram monitoring (Yurek,
Jakub & Menacho, 2015).

AS Severity Grading

•

Hypertrophy increases myocardial
oxygen demand and could lead to
ischemia, dysrhythmias, myocardial
infarction, and heart failure (McCance
& Huether, 2014).

•

AS is characterized by a relatively
benign course in patients with
asymptomatic disease but a rapid
downhill course with the onset of
symptoms (Kanwar, Thaden & Nkomo,
2018).

Implications for
Nursing Care
•

About 39% of patients admitted with
acute decompensation have no prior
diagnosis, highlighting the need for
increased identification of aortic
stenosis (Wald et al., 2018). Nurses
should incorporate assessment of AS
signs and symptoms into their routine
care; especially patients complaining
of reduced exercise capacity.

•

Teaching patients with AS to
recognize and immediately report
symptoms associated with the
disease progression can reduce
subjective denial of symptoms, time
to treatment, and mortality (Yurek,
Jakub & Menacho, 2015).

AS holds a poor survival rate unless
timely valve replacement is performed
(Kanwar, Thaden & Nkomo, 2018).

•

In the perioperative setting, patients
with aortic stenosis are at high risk of
experiencing cardiac complications.
Safe administration of anesthesia
requires prevention of any
hemodynamic change that decreases
cardiac output (Hines & Marschall,
2018).

•

Cardiopulmonary resuscitation is
typically ineffective in patients with
aortic stenosis; thus, education on the
disease and perioperative treatment is
extremely important for nurse
anesthetists (Hines & Marschall, 2018).

•

Signs and
Symptoms
Classic Triad (Joseph, Naqvi, Giri, and
Goldberg, 2017)
1.
2.
3.

Heart Failure or exercise
intolerance
Syncope
Exertion related angina

Kanwar, Thaden, and Nkomo (2018)
described the following additional
symptoms:

Table 1. Classification of Progressive Aortic Stenosis and Frequency of
Echocardiogram Monitoring (Yurek, Jakub & Menacho, 2015)

Hemodynamics

Significance of
Pathophysiology

•

Dyspnea occurs due to increased LV
filling pressure or the inability to
increase cardiac output during
exercise

•

Dizziness or syncope results from a
reduction in cerebral perfusion

•

Vague symptoms of tiredness or
fatigue

Table 2. Hemodynamic Parameters and the Effects of Aortic Stenosis (Cary &
Pearce, 2013).

Treatment

•

Medical Management
•
There is no effective pharmacologic treatment for AS (Joseph et al., 2017).
Balloon Valvuloplasty
•
A balloon is placed across the stenotic valve and inflated/deflated several times to
widen the valve area (Cary & Pearce, 2013)
•
Used in patients who are not able to receive an aortic valve replacement due to
comorbidities (Joseph et al., 2017).
•
Can be used as a bridge to SAVR or TAVR in unstable patients with high surgical risk,
but does not alter the pathology. The hemodynamic benefit lasts for only about 6
months. The chances of restenosis are high (Joseph et al., 2017).
Valve Replacement
•
Aortic valve replacement is recommended in symptomatic patients with severe AS
(Bhattacharyya et al., 2016)
•
Standard treatments of severe AS are surgical aortic valve replacement (SAVR) and
transcatheter aortic valve replacement (TAVR) (Joseph et al., 2017).
SAVR
Through open heart surgery, the aortic
valve is removed and a new valve is
sewn into the orifice (Cary & Pearce,
2013).
•
Considered the gold standard
treatment of severe AS and performed
with either mechanical or bioprosthetic
valves.
•
Surgical risk is calculated using the
Society of Thoracic Surgeons (STS)
score. Patients are classified as being
high surgical risk if STS score > 8%, or if
they have coexisting noncardiac
conditions that predict poor survival.
•
As compared with TAVR, the risk of
major bleeding and new-onset atrial
fibrillation are higher; however, the risk
of a major stroke and a major vascular
complications is less.
(Joseph et al., 2017)
•

TAVR
The replacement valve is located inside
a stent that is deployed over the
diseased valve via a transcatheter
approach (Cary & Pearce, 2013).
•
Indicated for inoperable, high-risk, and
intermediate-risk surgical patients as
an alternative to SAVR.
•
Less invasive as compared with SAVR
•
Commonly performed in a hybrid
operative room under general
anesthesia, but can also be performed
in the cardiac catheterization lab under
conscious sedation.
•
The most common approach for
implantation is transfemoral (TF).
•
Complications associated with TAVR
include stroke, vascular access-site
bleeding, paravalvular leak, and heart
block requiring permanent pacing.
(Estes & Kalra, 2018)

•

Hospitalization with acute
decompensation is an overlooked and
life-threatening problem in patients
with AS (Wald et al., 2018). Nurses
need to be hyperaware of the
hemodynamic status of patients with
AS.
Medication compliance following
valve replacement is vital to
successful recovery and maintenance.
Medication education for the patient
and family members is very
important. As some medications can
be expensive, nursing should consult
case management for assistance to
help ensure patient compliance (Estes
& Kalra, 2018).

Conclusions
•

It is anticipated that the prevalence
of AS will double in the next 20 years
(Hines & Marschall, 2018). Health
care providers need to make
understanding the pathophysiological
processes, clinical manifestations,
symptoms associated with the
disease progression, treatment
options, and nursing implications a
priority.

•

Proper management of patients with
AS requires an understanding of the
criteria used to define the disease
severity (Joseph et al., 2017).

•

With an increase in TAVR procedures
for AS, nurses must expand their
knowledge and scope to care for
these patients. Better understanding
of the procedure and possible
complications leads to better nursing
care and patient outcomes (Estes &
Kalra, 2018).

•

Early recognition and management of
AS is of utmost importance because
untreated symptomatic severe
disease is universally fatal (Kanwar,
Thaden & Nkomo, 2018).

•

It is critical for nursing care to evolve
and grow in tandem with the
increased TAVR population to
integrate the complex care of these
patients to provide optimal care and
improve patient outcomes (Estes &
Kalra, 2018).

•

Figure 1. Summary of pathological processes occurring within the valve during
AS (Hines & Marschall, 2018).
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